March 18, 2026  - illumiSonics Inc., a leading innovator in advanced biomedical imaging technologies, is pleased to announce the appointment of James Tweel as Principal Research Scientist. Dr. Tweel brings extensive expertise in biomedical imaging and has played a critical role in the development of the company’s core technologies, PARS® (Photon Absorption Remote Sensing) and MLI® (Multi-Laser Imaging), which serve as central pillars of illumiSonics’ proprietary imaging platf

Unenhanced MLI® of an unstained pelvic biopsy specimen readily identifies areas of endometriosis.

Unenhanced whole slide MLI® of human skin cancer demonstrating basal cell carcinoma (BCC) architecture. Tissue and interpretation from Dr. Marie Abi Daoud, University of Calgary. 

Unenhanced MLI® alongside MLI® virtual H&E showing the diagnostic features of human breast ductal carcinoma in situ. Tissue courtesy of Ontario Institute for Cancer Research. 

MLI® virtual HER2 staining performance compared against ground truth HER2 Immunohistochemical staining. MLI® virtual HER2 staining shows strong concordance and localization across the distribution of HER2 seen in clinical samples. 

Unenhanced MLI® of mouse eye cross section showing ocular anatomy, captured in collaboration with Prof. Kathleen Hill, Western University, Canada.  

MLI® whole slide of invasive ductal carcinoma with admixed ductal carcinoma in situ. Tissue courtesy of Ontario Institute for Cancer Research. 

​ Label-free, multiplex whole-slide imaging from unstained FFPE tissue reduces pre-analytic variables and delivers AI-ready data....

September 22, 2025 - illumiSonics Inc., a leading innovator in advanced biomedical imaging technologies, is pleased to announce the...

Waterloo, ON - illumiSonics announces the publication of a new study exploring multi-wavelength photon absorption remote sensing used...

Boston, MA and Waterloo, ON – Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics...

Waterloo, ON - illumiSonics announces the publication of a new study exploring the capabilities of Photon Absorption Remote Sensing...

Waterloo, ON - illumiSonics annouces the publication of a successful clinical study evaluating the diagnostic concordance of PARS Virtual...

June 18, 2024 - Toronto, ON - illumiSonics Inc., (“company”) a leading company in optical imaging systems providing unprecedented...

Featured on CTV News Kitchener. A cancer detecting system built from scratch at the University of Waterloo (UW) is nearing completion and...

Featured in David Johnston Research + Technology Park newsletter. Read more here .

Waterloo, ON - Pathologists rely on histochemical stains to impart contrast in thin translucent tissue samples, revealing tissue...

November 9, 2023 – illumiSonics, Inc. announces the publication of a landmark clinical validation study in breast cancer diagnosis. The...

April 6, 2023 – illumiSonics Inc., a leading company in label-free imaging systems for precision diagnostics, is proud to announce that...

December, 2022 - illumiSonics Inc. is pleased to announce that Glen E. Mackey has joined the company as a member of the Board of...